Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PGAM5 inhibitors(PGAM family member 5, mitochondrial serine/threonine protein phosphatase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC55H64N6O4 |
InChIKeyOITTXMIOSJEXLY-UHFFFAOYSA-N |
CAS Registry2102347-47-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ischemic stroke | Preclinical | CN | 01 Jul 2021 |